Skip to main content
SpringerLink
Log in

A traditional Japanese medicine—Hangeshashinto (TJ-14)—alleviates chemoradiation-induced mucositis and improves rates of treatment completion

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Oral mucositis induced by radiation or chemoradiation can cause devastating quality of life issues for patients undergoing treatment for head and neck cancer. In this study, we investigated the efficacy of a traditional Japanese medicine—Hangeshashinto (TJ-14)—for (chemo)radiation-induced oral mucositis.

Methods

Eighty patients who underwent whole neck radiation of >60 Gy with or without chemotherapy (high-dose cisplatin or low-dose docetaxel) were enrolled in this retrospective study; 40 had received TJ-14 during treatment, and 40 had not (controls). Factors related to alleviation of oral mucositis were identified by multivariate logistic regression analysis. Rates of completion of (chemo)radiation treatments were compared between the patients who received TJ-14 and the control group according to the treatment regimen. The comparison of the nutrition status between groups was also performed.

Results

Multivariate analysis indicated that the use of TJ-14 (p = 0.019), gender (p = 0.024), and primary tumor location (p = 0.028) were significant factors associated with the severity of oral mucositis. TJ-14 was associated with a significantly improved rate of completion of chemoradiation with cisplatin (p = 0.002). In the investigation of nutritional status, only serum albumin was significantly maintained better in the TJ-14 group than the control group in terms of mean change before and after (chemo)radiation (p = 0.024).

Conclusions

The present study indicates that TJ-14 is effective for ameliorating oral mucositis induced by (chemo)radiation in patients with head and neck cancers. TJ-14 was associated with improved completion rates of chemoradiation treatments with cisplatin. A randomized controlled trial is necessary to confirm the efficacy of TJ-14 for chemoradiation-induced mucositis in head and neck cancer patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Forastiere AA, Goepfert H, Maor M et al (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091–2098

    Article  CAS  PubMed  Google Scholar 

  2. Bourhis J, Lapeyre M, Tortochaux et al (2011) Accelerated radiotherapy and concomitant high dose chemotherapy in non resectable stage IV locally advanced HNSCC: results of a GORTEC randomized trial. Radiother Oncol 100:56–61. doi:10.1016/j.radonc.2011.07.006

    Article  PubMed  Google Scholar 

  3. Sonis ST (2011) Oral mucositis. Anti-Cancer Drugs 22:607–612

    Article  CAS  PubMed  Google Scholar 

  4. Robertson C, Robertson AG, Hendry JH et al (1998) Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 40:319–329

    Article  CAS  PubMed  Google Scholar 

  5. Bese NS, Hendry J, Jeremic B (2007) Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys 68:654–661

    Article  PubMed  Google Scholar 

  6. Withers HR, Taylor JM, Maciejewski B (1988) The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131–146

    Article  CAS  PubMed  Google Scholar 

  7. Herrmann T, Jakubek A, Trott KR (1994) The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck. Strahlenther Onkol 170:545–549

    CAS  PubMed  Google Scholar 

  8. Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski B (2003) Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys 56:399–412

    Article  PubMed  Google Scholar 

  9. Russo G, Haddad R, Posner M, Machtay M (2008) Radiation treatment breaks and ulcerative mucositis in head and neck cancer. Oncologist 13:886–898. doi:10.1634/theoncologist 2008–0024

    Article  PubMed  Google Scholar 

  10. Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205

    CAS  PubMed  Google Scholar 

  11. Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831

    Article  CAS  PubMed  Google Scholar 

  12. Peterson DE, Bensadoun RJ, Roila F et al (2009) Management of oral and gastrointestinal mucositis: ESMO clinical recommendations. Ann Oncol 20:174–177

    Article  PubMed  Google Scholar 

  13. Quinn B, Potting CM, Stone R et al (2008) Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplantation patients. Eur J Cancer 44:61–72

    Article  PubMed  Google Scholar 

  14. Henke M, Alfonsi M, Foa P et al (2011) Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 29:2815–2820. doi:10.1200/JCO.2010.32.4103. Epub 2011 Jun 13

    Article  CAS  PubMed  Google Scholar 

  15. Bensinger W, Schubert M, Ang KK et al (2008) NCCN Task Force Report. Prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 6(1):S1–21, quiz S22-4

    CAS  PubMed  Google Scholar 

  16. Svanberg A, Ohrn K, Birgegard G (2010) Oral cryotherapy reduces mucositis and improves nutrition—a randomised controlled trial. J Clin Nurs 19:2146–2151. doi:10.1111/j.1365-2702.2010.03255.x

    Article  PubMed  Google Scholar 

  17. Scully C, Epstein J, Sonis S et al (2004) Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 26:77–84

    Article  PubMed  Google Scholar 

  18. Cowen D, Tardieu C, Schubert M et al (1997) Low energy Helium-Neon laser in the prevention of oral mucositis in patients undergoing bone marrow transplant: results of a double blind randomized trial. Int J Radiat Oncol Biol Phys 38:697–703

    Article  CAS  PubMed  Google Scholar 

  19. Cheah KY, Howarth GS, Yazbeck R et al (2009) Grape seed extract protects IEC-6 cells from chemotherapy-induced cytotoxicity and improves parameters of small intestinal mucositis in rats with experimentally-induced mucositis. Cancer Biol Ther 8:382–390

    Article  CAS  PubMed  Google Scholar 

  20. Cheah KY, Bastian SE, Acott TM et al (2013) Grape seed extract reduces the sevility of selected disease markers in the proximal colon of dextran sulphate sodium-induced colitis in rats. Dig Dis Sci 58:970–977

    Article  PubMed  Google Scholar 

  21. Wright TH, Yazbeck R, Lymn KA et al (2009) The herbal extract, Iberogast®, improves jejunal integrity in rats with 5-fluorouracil (5-FU)-induced mucositis. Cancer Biol Ther 8:923–929

    Article  PubMed  Google Scholar 

  22. Kono T, Satomi M, Chisato N et al (2010) Topical application of Hangeshashinto (TJ-14) in the treatment of chemotherapy- induced oral mucositis. World J Oncol 1:232–235

    Google Scholar 

  23. Gibson RJ, Keefe DMK, Lalla RV et al (2013) Systemic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21:313–326

    Article  PubMed  Google Scholar 

  24. Bensinger WB, Schubert M, Ang KK et al (2008) NCCN task force report: prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 6(1):S1–S23

    CAS  PubMed  Google Scholar 

  25. Hensley ML, Hagerty KL, Kewalramani T et al (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–145

    Article  CAS  PubMed  Google Scholar 

  26. Peterson DE, Bensadoun RJ, Rolia F (2011) Management of oral and gastrointestinal mucositis: ESMO clinical practice guidelines. Ann Oncol 22(6):vi78–vi84

    PubMed Central  PubMed  Google Scholar 

  27. Le QT, Kim HE, Schneider CJ et al (2011) Palifermin reduces severe mucositis in definitive chemoradiation of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29:2808–2814

    Article  CAS  PubMed  Google Scholar 

  28. Bossi P, Locati LD, Licitra L (2012) Palifermin in prevention of head and neck cancer radiation-induced mucositis: not yet a definitive word on safety and efficacy profile. J Clin Oncol 30(564–565):565–567. doi:10.1200/JCO.2011.39.1136

    Google Scholar 

  29. Satoh H, Ishikawa H, Murakami O et al (1999) Reduction by Hange-Shashin-To (TJ-14), a herbal medicine on gastrointestinal tract complications induced by CPT-11 containing chemotherapy. Cancer Res Ther Contr 7:321–323

    Google Scholar 

  30. Sonis ST (2004) A biological approach to mucositis. J Support Oncol 2:21–36

    PubMed  Google Scholar 

  31. Samosorn S, Tanwirat B, Muhamad N et al (2009) Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group. Bioorg Med Chem 17:3866–3872

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Grycova L, Dostal J, Marek R et al (2007) Quaternary protoberberine alkaloids. Phytochemistry 68:150–175

    Article  CAS  PubMed  Google Scholar 

  33. Hattori T, Nagamatsu T, Ito M, Suzuki Y (1989) Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine, and its mechanisms (2): effect on the release of corticosterone from adrenal glands. Jpn J Pharmacol 51:117–124

    Article  CAS  PubMed  Google Scholar 

  34. Kase Y, Saitoh K, Ishige A et al (1998) Mechanisms by which Hange-shashin-to reduces prostaglandin E2 levels. Biol Pharm Bull 21:1277–1281

    Article  CAS  PubMed  Google Scholar 

  35. Tawata M, Aida K, Noguchi T (1992) Anti-platelet action of isoliquiritigenin, an aldose reductase inhibitor in licorice. Eur J Pharmacol 212:87–92

    Article  CAS  PubMed  Google Scholar 

  36. Morimoto S, Tateishi N, Matsuda T et al (1998) Novel hydrogen peroxide metabolism in suspension cells of Scutellaria baicalensis Georgi. J Biol Chem 273:12606–12611

    Article  CAS  PubMed  Google Scholar 

  37. Kase Y, Hayakawa T, Ishige A et al (1997) The effects of Hange-shashin-to on the content of prostaglandin E2 and water absorption in the large intestine of rats. Biol Pharm Bull 20:954–957

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

There is no financial support for the present study, and the authors have declared no conflicts of interest. The authors are fully responsible for the content of this paper. All authors reviewed and approved the paper.

Author information

Authors and Affiliations

  1. Department of Otorhinolaryngology-Head & Neck Surgery, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 3598513, Japan

    Taku Yamashita, Koji Araki, Masayuki Tomifuji, Daisuke Kamide, Yuya Tanaka & Akihiro Shiotani

Authors
  1. Taku Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Koji Araki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masayuki Tomifuji
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Daisuke Kamide
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuya Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Akihiro Shiotani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Taku Yamashita.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yamashita, T., Araki, K., Tomifuji, M. et al. A traditional Japanese medicine—Hangeshashinto (TJ-14)—alleviates chemoradiation-induced mucositis and improves rates of treatment completion. Support Care Cancer 23, 29–35 (2015). https://doi.org/10.1007/s00520-014-2315-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2315-z

Keywords

Search

Navigation